Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study

NCT02990858 is registered in ClinicalTrials.gov with CytoDyn, Inc. as lead sponsor.

NCT NCT02990858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02990858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study
Lead sponsor
CytoDyn, Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
November 3, 2016
Completion date
July 10, 2022
Enrollment
43 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)